EVA Group and Lilly enter into a partnership in Egypt

EVA Group signed a strategic partnership agreement with Lilly to import, sell, market, and distribute Lilly’s brands in Egypt


Cairo, December 10th, 2020 – EVA Group entered a successful strategic partnership with Eli Lilly and Company, a global healthcare leader and a significant contributor to the healthcare industry in the Egyptian market.

Under this partnership, EVA Group will be holding the rights to sell, market, and distribute Lilly’s products, mainly in the areas of Oncology, Diabetes, Central Nervous System (CNS), Musculoskeletal, Urology, and Autoimmune diseases. This partnership aims to increase healthcare professionals’ engagements and expand access to medicines to patients in Egypt who need them.

Riad Armanious, EVA Group Managing Director said: “The partnership between EVA Group and Lilly is a great milestone for both companies as well as Healthcare Providers and patients who need Lilly’s innovative therapies. At EVA we are looking forward to leveraging our capabilities and expertise around Egypt to bring Lilly’s innovative products to patients who need them. We are proud to be partnering with a Global Healthcare leader such as Lilly, and we will continue to expand our portfolio of products in both Egypt and international markets to advance treatment options for patients. This partnership today comes as a continuation of the multiple successes achieved by EVA in providing the latest medications in Egypt and around 40 countries around the world, including medicines for various chronic diseases.” In regards of distribution, Co-Managing Director of EVA Group, Linda Armanious, added: “With our in-depth knowledge of the local market and commercialization capabilities, we will expand the access of innovative healthcare in Egypt.”

Ahmed Fahmy, General Manager for Lilly North East Africa, added “For over 140 years, Lilly has been committed to our promise of uniting caring with discovery to make life better for people around the world. Through our partnership with EVA Group, Lilly’s products will continue to be present in Egypt, fulfilling our promise and ensuring that our medicines are accessible to more patients in Egypt who need them.”


About EVA Group

EVA Group is one of the major multinational groups specialized in manufacturing and distributing pharmaceutical products, headquartering in Cairo, Egypt while operating in more than 40 countries and one of the fastest-growing pharmaceutical groups in the MENA region. With a 5250-strong team of the most competent pharmaceutical professionals and state-of-the-art facilities, EVA Group is equipped with cutting-edge technology and is internationally recognized for innovation and the highest international quality standards. To learn more about EVA Group, please visit: https://www.evapharma.com/evagroup/

About Eli Lilly and Company

 Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. The company was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

download as pdf